Recombinant DNA Technology Reshaping Protein Production in California’s Healthcare Facilities
The landscape of biopharmaceutical production in the United States is undergoing a significant transformation, particularly within the specialized field of protein synthesis. In California, medical research centers are increasingly focusing on recombinant DNA technology to produce high-purity proteins. These innovations are primarily aimed at addressing critical use cases such as hypovolemia...
0 Commentarii 0 Distribuiri 177 Views 0 previzualizare